Luminal A is the most common molecular subtype of breast cancer, accounting for approximately 50% of invasive breast cancer cases [2], and is characterized as estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), HER2/Neu-negative, with low Ki-67 expression [3]
It is about the small, consistent choiceslike choosing a bioavailable supplement or drinking enough waterthat add up to a significant impact over time
Sustained application keeps building
p62 can bind to Keap1 through its Keap1-interacting region, which causes Nrf2 to be released from the Keap1 complex, preventing the inhibitory effect of Keap1 on Nrf2
And I do think that stuff seems to have a positive effect
Therefore, it's crucial to consult with a healthcare professional before using TAD Glutathione or any glutathione product, especially if you have underlying health conditions or concerns